Price Setting Bill Is No Panacea for Patients

The drug pricing deal in the Build Back Better Act sounded like welcome news to many. As someone who worked for the previous two administrations as they attempted to lower drug prices, I know how difficult making deals like this can be. Despite these difficulties, it is incumbent on policymakers to thoroughly understand the potential consequences of legislation.

Read the source article at RealClearPolicy
2021-11-26 06:07:00